rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Cipla Ltd.

500087 CIPLA Group (A)

22 Jul,15:29
1490.00
4.85 (0.33%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Cipla Ltd.

BUYSELL
68,963 1,485.15 1,506.75 - 1,470.05 1,581.70 - 1,028.00 120,332.41
NSE | BSE

Cipla Ltd.

CIPLA

22 Jul,15:55
1490.00
4.50 (0.30%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Cipla Ltd.

BUYSELL
1,328,847 1485.50 1,507.05 - 1,470.65 1,582.00 - 1,027.00 1,984,566,552.15

News for Cipla Ltd.

Cipla Faces Rs...
Cipla Faces Rs 773 Crore I-T Demand: Details - Business News
Cipla receives a Rs 773.44 crore demand notice from the income tax department for assessment years 2015-16 to 2022-23. The company plans to appeal the order.
Jul 16, 2024 16:40
Pharma Budget...
Pharma Budget Wish List: Tax Benefits, IP Rights
Pharma industry bodies call for tax incentives, stronger IP regime and R&D support in the upcoming Union Budget to boost domestic growth.
Jul 07, 2024 11:15
Orchid Pharma &...
Orchid Pharma & Cipla Partner for New Antibiotic in India
Orchid Pharma and Cipla collaborate to distribute Cefepime-Enmetazobactam, a new antibiotic for complicated infections, across India. The partnership aims to combat antimicrobial resistance and...
Jun 28, 2024 19:42
Cipla Gets USFDA...
Cipla Gets USFDA Nod for Generic Lanreotide Injection
Cipla receives USFDA approval to market generic Lanreotide injection, a treatment for acromegaly and other conditions. The drug is a therapeutic equivalent to Somatuline Depot Injection.
May 22, 2024 12:13
Cipla Promoters...
Cipla Promoters Sell 2.53% Stake for Rs 2,750 Cr | News
Cipla promoters offload 2.53% stake for Rs 2,750 crore to create liquidity for philanthropy and other needs. The deal was completed through a block deal on the NSE, with buyers including Aditya...
May 15, 2024 19:25

More News for Cipla Ltd. »

(Rs. Crore)

Financial Results of Cipla Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales16,574.3415,790.6013,091.7913,900.5812,659.15
Operating profit4,484.153,792.583,366.473,721.562,707.29
Interest20.2527.0226.9345.0736.05
Gross profit5,534.564,222.354,006.243,906.773,564.09
EPS (Rs)50.5031.1436.6630.6128.75

See more in Research Center »

Statements:Balance Sheet  |  P&L  |  Cash Flow
More:Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

About Cipla Ltd.

Cipla Limited (stylized as Cipla) is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia

News for Pharmaceuticals and health care

Air India A350 to...
Air India A350 to Fly to US from November | New York JFK & Newark Flights
Air India will start operating its flagship Airbus A350 on ultra-long haul routes to the US from November, beginning with Delhi-New York JFK flights. Premium economy class will be offered.
Jul 22, 2024 17:55
Supertech...
Supertech Township Projects Faces Insolvency Over Rs 216 Crore Debt
The National Company Law Tribunal has ordered insolvency proceedings against Supertech Township Projects over a Rs 216.92 crore default by Punjab & Sind Bank. This is the third Supertech group firm...
Jul 22, 2024 17:55
Sanstar IPO...
Sanstar IPO Over-Subscribed 13.47 Times on Day 2
Sanstar Ltd's IPO received 13.47 times subscription on the second day, with strong demand from non-institutional investors and RIIs. The IPO aims to raise Rs 510 crore for expansion and debt...
Jul 22, 2024 17:46
JNPA to Build Rs...
JNPA to Build Rs 285 cr Agri Processing Facility
JNPA receives approval to build India's first agricultural commodity-based processing facility, aimed at mitigating wastage and extending shelf life. The Rs 285 crore project will be built on a...
Jul 22, 2024 17:43
Sebi Finds No...
Sebi Finds No Evidence of Unfair Trading on Poll Results Day
Sebi has not received any specific information on unfair trading during the stock market crash on June 4, 2024, following the Lok Sabha poll results, according to a parliamentary statement. The...
Jul 22, 2024 17:42

More News »

Top News

India's...
India's Dependence on China for Critical Minerals: Economic Survey
India's Economic Survey highlights the need to address dependence on China for critical minerals essential for green transition, while urging diversification of energy sources and strategic...
Jul 22, 2024 17:57
India Criticizes...
India Criticizes EU's Carbon Tax on Imports: Contravenes Paris Agreement
India condemns the EU's planned carbon tax on energy-intensive goods from developing countries, arguing it violates the spirit of the Paris Agreement and unfairly burdens developing nations.
Jul 22, 2024 17:57
Air India A350 to...
Air India A350 to Fly to US from November | New York JFK & Newark Flights
Air India will start operating its flagship Airbus A350 on ultra-long haul routes to the US from November, beginning with Delhi-New York JFK flights. Premium economy class will be offered.
Jul 22, 2024 17:55
Supertech...
Supertech Township Projects Faces Insolvency Over Rs 216 Crore Debt
The National Company Law Tribunal has ordered insolvency proceedings against Supertech Township Projects over a Rs 216.92 crore default by Punjab & Sind Bank. This is the third Supertech group firm...
Jul 22, 2024 17:55
Sanstar IPO...
Sanstar IPO Over-Subscribed 13.47 Times on Day 2
Sanstar Ltd's IPO received 13.47 times subscription on the second day, with strong demand from non-institutional investors and RIIs. The IPO aims to raise Rs 510 crore for expansion and debt...
Jul 22, 2024 17:46

More Top News »

Report Card

PE Ratios
29.38
EPS (Rs.)
50.50
Sales (Rs. Cr)
4,036.66
Face Value (Rs.)
2
Net Profit Margin (%)
15.91
Last Bonus
3:2
Last Dividend(%)
650
Return on Average Equity
10.21

BSE Announcements from Cipla Ltd. (See all)

announcement Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation - 3 day(s) ago
announcement Announcement under Regulation 30 (LODR)-Newspaper Publication - 4 day(s) ago

Compare 'Cipla Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,593.65
  • Compare
  • Divi's Laboratories Ltd.
  • 4,582.30
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,185.30
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,665.10
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,053.90
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,517.15
  • Compare
  • Max Healthcare Institute Ltd.
  • 933.40
  • Compare
  • Alkem Laboratories Ltd.
  • 5,265.25
  • Compare

Mutual Funds Invested

Most Active

  • Change (Rs.)
  •  

REDIFFGURUS

Subject: Inheritance Received - Investment Strategy...

I was running a bussiness from last seven year with...

Im a 55-year-old man working in a nationalized bank....

Dear Sh.Vivek Ji - I am aged 45, unmarried. I am an...

Sir My age is 53. My PF contribution from salary is...

I have hdfc small cap, multicap, flexicap funds all...

More REDIFFGURUS

RediffGurus

Money question

Hello Sir I am an NRI and I still have an old SB...

Cipla Ltd. performance snapshot

If you had invested Rs.  in Cipla Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
Cipla Ltd.
Share Price » Fundamentals » Financial » Technicals » Option Chain » Trade Now »

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume

ALL MONEYWIZ PAGES

rediff on the net© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
Close
Add Cipla Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Cipla Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close